股价表现 - Zoetis (ZTS) 最近的股价为$165.69，较前一个交易日下跌了0.1% [1] - Zoetis 过去一个月的股价下跌了8.95%，落后于医疗行业的0.6%和标普500指数的2.57% [2] 财务预测 - Zoetis 将于2024年5月2日发布财报，预计每股收益为$1.35，同比增长3.05%，营收预期为$2.14亿，同比增长7.03% [3] - Zacks Consensus Estimates 预计 Zoetis 全年每股收益为$5.80，营收为$91.6亿，同比分别增长9.02%和7.17% [4] 分析师预测 - 投资者应关注分析师对 Zoetis 的最新预测修订，这些修订通常反映最新的短期业务趋势 [5] - Zacks Rank 模型显示预测变化与近期股价直接相关，Zoetis 目前的 Zacks Rank 为 4 (卖出) [6] 行业比较 - Zoetis 目前的前瞻市盈率为28.62，高于行业平均值15.23 [7] - ZTS 目前的 PEG 比率为2.53，高于行业平均值1.4 [8] 行业排名 - 医疗-药品行业属于医疗部门，目前行业排名为143，位于所有250+行业的后44% [9] - Zacks Industry Rank 显示排名靠前的行业通常表现优于排名靠后的行业 [10] 投资建议 - 投资者应使用 Zacks.com 监控所有这些影响股价的指标，并在未来的交易中持续关注 [11]

Zoetis公司业绩 - Zoetis自2013年分拆以来，每年都实现了正增长的每股收益[2] - Zoetis的平均年度每股收益增长率为15.9%，自2013年成为上市公司以来[2] - Zoetis是整个市场上最高股息增长股票之一，自2013年以来的股息增长年复合增长率接近25%[2] - Zoetis在过去十年中远远超过标普500指数，股价回报率为492%，而标普500指数为176%[3] Zoetis公司市场前景 - 孤独症流行病对Zoetis股价有利[5] - 人们越来越依赖宠物来获得爱和情感[13] - 宠物行业的发展趋势对Zoetis有利[14] - Zoetis在动物保健市场处于领先地位，具有较高的定价权和较长的增长空间[23] - Zoetis在伴侣动物市场的重点可能会带来更高的增长率[29] - Zoetis在新兴市场的宠物拥有率较低，但随着可支配收入的增加，这为公司提供了巨大的市场机会[30] Zoetis公司投资价值 - Zoetis股票虽然不便宜，但由于缺乏监管和竞争，公司值得获得溢价估值[32] - Zoetis的股息增长稳定，与基本增长相匹配，为投资者提供了持续增长的机会[39] - Zoetis股票目前被低估，为投资者提供了购买这家优秀公司的机会[40] - ZTS公司正转向伴侣动物领域，减少对畜牧相关产品需求下降的担忧[43] - ZTS公司提供安全可靠增长的股息，因此在股价下跌时，该公司继续升高个人观察名单[43] - 新的现金投资将使Zoetis Inc.股票成为未来的首要目标，计划在4月初增加持仓[44]

FatCamera Introduction As you guys probably know, I like dividend growth investing. With dividend growth investing, you can compound your wealth in a sustainable way and if you invest in dividend growth stocks, the chances are high that you have exposure to high-quality and resilient companies. The composition of a dividend growth portfolio depends heavily on your time horizon, but if you have a lot of time on your side, it is a good idea to also buy some companies with high dividend growth rates. This brou ...

Particular financial metrics have been proven to indicate market-beating potential when analyzing stocks. Three examples are businesses with consistently growing dividend payments and a low payout ratio, steady share repurchases, and a high and rising return on invested capital. Finding companies that meet these requirements creates a "stocked pond" for us to fish in.One business swimming around in this stocked pond is animal health specialist Zoetis (ZTS 0.06%). It's achieved a total return above 500% sinc ...

公司介绍 - Zoetis Inc.是全球领先的动物健康公司，致力于通过推进动物护理来培育我们的世界和人类[3] - Zoetis在2023年实现了85亿美元的收入，拥有约14,100名员工[3] 参会信息 - Zoetis Inc.将参加2024年2月29日举行的美国银行证券2024动物健康峰会[1]

Zoetis, Inc. (ZTS) delivered fourth-quarter 2023 adjusted earnings (excluding one-time items) of $1.24 per share, which missed the Zacks Consensus Estimate of $1.33. In the year-ago quarter, the company delivered earnings of $1.15 per share.Total revenues grew 8% year over year to $2.21 billion, surpassing the Zacks Consensus Estimate of $2.19 billion in the reported quarter. Shares of Zoetis have gained 20.6% in the past year against the industry’s 2.8% decline.Image Source: Zacks Investment ResearchQuarte ...

营收情况 - Zoetis (ZTS)在2023年12月结束的季度报告显示，营收达到21亿美元，同比增长8.5%[1] - Zoetis的营收超出了Zacks Consensus Estimate的21.9亿美元，超出了1.04%[2] 每股收益 - 每股收益为1.24美元，较去年同期的1.15美元有所增长[1] - 每股收益也超出了预期，但为-6.77%，预期为1.33美元[2] 地理营收表现 - Zoetis在最近一个季度的地理营收表现良好，美国地区营收达到12.1亿美元，同比增长8.9%[5] 部门营收情况 - Zoetis的伴侣动物部门营收为5.07亿美元，同比增长12.7%[7] - Zoetis的伴侣动物部门营收达到14.5亿美元，同比增长11.1%[8] - Zoetis的家畜部门营收为7.45亿美元，同比增长4.9%[9] - Zoetis的家畜-家禽部门营收为1.27亿美元，同比增长10.4%[11] - Zoetis的伴侣动物-马匹部门营收为8800万美元，同比增长11.4%[12] - Zoetis的伴侣动物-狗和猫部门营收为13.6亿美元，同比增长11.1%[13] - Zoetis的家畜-猪部门营收为1.39亿美元，同比增长0.7%[14] - Zoetis的家畜-牛部门营收为4.01亿美元，同比增长6.4%[15]

Fourth Quarter and Full Year 2023 Financial Results Forward-looking Non-GAAP Financial Statements Information This presentation contains forward-looking statements, which reflect the current views of We use non-GAAP* financial measures, such as adjusted net income, adjusted diluted Zoetis with respect to: business plans or prospects, future operating or financial earnings per share and operational results (which exclude the impact of foreign exchange), performance, future guidance, future operating models; ...

Zoetis (ZTS) came out with quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.77%. A quarter ago, it was expected that this animal health company would post earnings of $1.35 per share when it actually produced earnings of $1.36, delivering a surprise of 0.74%.Over the last four quarters, the compa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-35797 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 46-0696167 (State or other j ...